ArticleBreast cancer (Dove Medical Press)2017

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response.

Sandra Jernström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.